⌘K

Login Start Free

Home/Filings/5/0001570523-18-000020

5//SEC Filing

DAILEY ROBERT JACKMAN 5

Accession 0001570523-18-000020

CIK 0001559356other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 5:03 PM ET

Size

20.8 KB

Accession

0001570523-18-000020

Insider Transaction Report

Form 5

Period: 2017-12-31

Immune Therapeutics, Inc.IMUN

DAILEY ROBERT JACKMAN

Other

Transactions

Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-12-14$0.07/sh+1,250$86→ 20,800,359 total
Purchase
Common stock
2016-12-14$0.07/sh+1,550$115→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.16/sh+1,000$161→ 20,800,359 total
Purchase
Common stock
2016-11-28$0.06/sh+1,000$62→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.16/sh+1,000$163→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-12-06$0.06/sh+1,000$59→ 20,800,359 total
Purchase
Common stock
2016-12-08$0.07/sh+500$37→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$63→ 20,800,359 total
Purchase
Common stock
2016-11-29$0.06/sh+1,000$61→ 20,800,359 total
Purchase
Common stock
2016-12-02$0.06/sh+1,000$63→ 20,800,359 total

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeother

Related Parties

1

filerCIK 0001570523

Filing Metadata

Form type: 5
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 5:03 PM ET
Size: 20.8 KB

View on SEC.gov